The Size of the North America Intraosseous Infusion Devices Market is valued at USD 1.23 Billion in 2023 and is expected to grow at a CAGR of 7.8%, to reach USD 1.79 billion by 2028 during the forecast period 2023 to 2028.
The market for intraosseous infusion devices is predicted to grow in North America over the next few years as peripheral venous access fails in cardiac resuscitation, resulting in a rise in intraosseous infusion devices.
The intraosseous infusion device market is rapidly expanding in North America, owing to increased emergency department visits and chronic conditions such as major accidents, cardiovascular disease, obesity, and significant burns, linked to higher hospitalization rates.
Due to a growth in emergency medical situations, chronic illness problems that can lead to hospitalization, inactive lifestyles, and high success rates, intraosseous infusion devices are becoming increasingly popular.
Due to a growth in emergency surgeries, the market for intraosseous infusion devices is likely to develop in North America throughout the forecast period.
Instruments for intraosseous infusion are becoming more frequent in military medical institutions and the medical emergencies that result from them. Increased demand for critical and emergency operations and a rising incidence of admission to acute and emergency hospitals will likely benefit the intraosseous infusion devices market in North America in the future years. Patients under six are considered healthy enough to receive automatic infusions. Semi-skilled healthcare providers can do intraosseous access with only a few hours of training. In addition, the introduction of emergency medical training simulators is projected to aid the growth of the intraosseous infusion devices market in North America.
The most considerable limits on market expansion are the high risk of compartment syndrome and restrictions on use in people with osteoporosis. Other impediments to commercial growth include an increased risk of compartment syndrome, which causes fluids and medications to gushed into soft tissues, and restrictions on use in persons with severe osteoporosis and hypovolemic situations. In addition, intraosseous access carries the hazards of extravasation, soft-tissue necrosis, bone fractures or injury to the growth plates, drug penetration, inflammation, subcutaneous abscess, osteomyelitis, and embolic consequences. Fluid extravasation is the most common problem.
This research report on the North America Intraosseous Infusion Devices Market has been segmented and sub-segmented into the following categories.
By Product Type:
By Technology:
By End User:
By Route of Administration:
By Country:
Geographically, the North American region now leads the global market and is likely to continue to do so during the forecast period. The North American area now leads the global market and is expected to remain so for the foreseeable future. The high frequency of cardiovascular disorders, chronic illnesses, emergency medical circumstances, and obesity plays a role in the area market's expansion. Furthermore, several key market players in the area and their networks are expected to aid market expansion in North America.
Furthermore, increased physician and patient awareness of novel treatment procedures and technologies and considerable government investments in technology enable easy and quick drug administration to contribute to the market's growth in North America.
The U.S Intraosseous Infusion Devices market held the most significant share of the autologous matrix-induced chondrogenesis market in North America, owing to the rising prevalence of bone and joint issues and the growing geriatric and obese population. Factors like this are positively impacting the market growth in this region.
The Canada Intraosseous Infusion Devices Market has the most significant growth.
According to recent data from the American Orthopaedic Society for Sports Medicine, over 3.5 million athletes in the United States require medical attention due to sports injuries.
KEY MARKET PLAYERS
Promising Companies leading the North America Intraosseous Infusion Devices Market Profiled in the Report are PerSys Medical, Aero Healthcare, Biopsybell, Aero Healthcare, Teleflex, Pyng Medical Corp, Cook Medical Incorporated.,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region